UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.903

Sortiert nach

Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease (NAFLD) in the general population

Alimentary pharmacology & therapeutics, 2017-08, Vol.46 (4), p.447-456

2017

Link zum Volltext

Verfügbarkeit prüfen

Meta‐analysis: the association of hepatitis B virus genotypes and hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2013-03, Vol.37 (5), p.517-526

2013

Link zum Volltext

Verfügbarkeit prüfen

Review article: long‐term safety of oral anti‐viral treatment for chronic hepatitis B

Alimentary pharmacology & therapeutics, 2018-03, Vol.47 (6), p.730-737

2018

Link zum Volltext

Verfügbarkeit prüfen

PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

Alimentary pharmacology & therapeutics, 2014-03, Vol.39 (5), p.532-539

2014

Link zum Volltext

Verfügbarkeit prüfen

Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (6), p.617-627

2017

Link zum Volltext

Verfügbarkeit prüfen

Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments

Alimentary pharmacology & therapeutics, 2014-02, Vol.39 (3), p.254-269

2014

Link zum Volltext

Verfügbarkeit prüfen

Meta‐analysis: the efficacy of anti‐viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B‐related hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2011-05, Vol.33 (10), p.1104-1112

2011

Link zum Volltext

Verfügbarkeit prüfen

Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B

Journal of viral hepatitis, 2009-01, Vol.16 (1), p.36-44

2009

Link zum Volltext

Verfügbarkeit prüfen

Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis

Alimentary pharmacology & therapeutics, 2017-11, Vol.46 (10), p.1001-1010

2017

Link zum Volltext

Verfügbarkeit prüfen

Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2017-07, Vol.46 (2), p.175-182

2017

Link zum Volltext

Verfügbarkeit prüfen

Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011–2016

Journal of internal medicine, 2020-06, Vol.287 (6), p.711-722

2020

Link zum Volltext

Verfügbarkeit prüfen

Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B – a prospective cohort study with paired transient elastography examinations

Alimentary pharmacology & therapeutics, 2014-04, Vol.39 (8), p.883-893

2014

Link zum Volltext

Verfügbarkeit prüfen

Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B

Alimentary pharmacology & therapeutics, 2010-12, Vol.32 (11‐12), p.1323-1331

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region—the GO ASIA initiative

Alimentary pharmacology & therapeutics, 2018-03, Vol.47 (6), p.816-825

2018

Link zum Volltext

Verfügbarkeit prüfen

Non‐invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B

Alimentary pharmacology & therapeutics, 2014-01, Vol.39 (2), p.197-208

2014

Link zum Volltext

Verfügbarkeit prüfen

Hand hygiene and risk of influenza virus infections in the community: a systematic review and meta-analysis

Epidemiology and infection, 2014-05, Vol.142 (5), p.922-932

2014

Link zum Volltext

Verfügbarkeit prüfen

Predictors of relapse in chronic hepatitis B after discontinuation of anti‐viral therapy

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (3), p.344-352

2011

Link zum Volltext

Verfügbarkeit prüfen

Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers

Alimentary pharmacology & therapeutics, 2012-12, Vol.36 (11-12), p.1057-1066

2012

Link zum Volltext

Verfügbarkeit prüfen

Gestational diabetes mellitus in five ethnic groups: a comparison of their clinical characteristics

Diabetic medicine, 2012-03, Vol.29 (3), p.366-371

Wong, V. W.

2012

Link zum Volltext

Verfügbarkeit prüfen

Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2008-11, Vol.28 (9), p.1067-1077

2008

Link zum Volltext

Verfügbarkeit prüfen

Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years

Alimentary pharmacology & therapeutics, 2012-06, Vol.35 (11), p.1326-1335

2012

Link zum Volltext

Verfügbarkeit prüfen

Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B‐related hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2016-04, Vol.43 (7), p.802-813

2016

Link zum Volltext

Verfügbarkeit prüfen

Bacterial endotoxin and non‐alcoholic fatty liver disease in the general population: a prospective cohort study

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (6), p.731-740

2015

Link zum Volltext

Verfügbarkeit prüfen

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

Gut, 2009-01, Vol.58 (1), p.111-117

2009

Link zum Volltext

Verfügbarkeit prüfen

Long‐term use of oral nucleos(t)ide analogues for chronic hepatitis B does not increase cancer risk – a cohort study of 44 494 subjects

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (9), p.1213-1224

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 3.903

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.460)
Mit Volltextzugriff
(3.535)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.672)
Life Sciences & Biomedicine
(1.929)
Humans
(1.588)
Female
(967)
Male
(909)
Biological And Medical Sciences
(693)
Middle Aged
(576)
Medical Sciences
(553)
Adult
(522)
Physical Sciences
(491)
Animals
(457)
Aged
(433)
Technology
(400)
Physics
(322)
Risk Factors
(227)
Engineering
(221)
Adolescent
(211)
Treatment Outcome
(211)
Oncology
(203)
Fundamental And Applied Biological Sciences. Psychology
(188)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease (NAFLD) in the general population

Meta‐analysis: the association of hepatitis B virus genotypes and hepatocellular carcinoma

Review article: long‐term safety of oral anti‐viral treatment for chronic hepatitis B

PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments

Meta‐analysis: the efficacy of anti‐viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B‐related hepatocellular carcinoma

Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B

Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis

Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease

Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011–2016

Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B – a prospective cohort study with paired transient elastography examinations

Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B

Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region—the GO ASIA initiative

Non‐invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B

Hand hygiene and risk of influenza virus infections in the community: a systematic review and meta-analysis

Predictors of relapse in chronic hepatitis B after discontinuation of anti‐viral therapy

Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers

Gestational diabetes mellitus in five ethnic groups: a comparison of their clinical characteristics

Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma

Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years

Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B‐related hepatocellular carcinoma

Bacterial endotoxin and non‐alcoholic fatty liver disease in the general population: a prospective cohort study

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

Long‐term use of oral nucleos(t)ide analogues for chronic hepatitis B does not increase cancer risk – a cohort study of 44 494 subjects

Suchergebnisse filtern